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Background: Rumex species are traditionally used for the treatment of neurological disorders including headache,
migraine, depression, paralysis etc. Several species have been scientifically validated for antioxidant and anticholinestrase
potentials. This study aims to investigate Rumex hastatus D. Don crude methanolic extract, subsequent fractions,
saponins and flavonoids for acetylcholinestrase, butyrylcholinestrase inhibition and diverse antioxidant activities
to validate its folkloric uses in neurological disorders. Rumex hastatus crude methanolic extract (Rh. Cr), subsequent
fractions; n-hexane (Rh. Hex), chloroform (Rh. Chf), ethyl acetate (Rh. EtAc), aqueous fraction (Rh. Aq), crude saponins
(Rh. Sp) and flavonoids (Rh. Fl) were investigated against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE)
at various concentrations (125, 250, 500, 1000 μg/mL) using Ellman’s spectrophotometric analysis. Antioxidant potentials
of Rh. Sp and Rh. Fl were evaluated using DPPH, H2O2 and ABTS free radical scavenging assays at 62.5, 125, 250, 500,
1000 μg/mL.
Results: All the test samples showed concentration dependent cholinesterase inhibition and radicals scavenging
activity. The AChE inhibition potential of Rh. Sp and Rh. Fl were most prominent i.e., 81.67 ± 0.88 and 91.62 ± 1.67 at
highest concentration with IC50 135 and 20 μg/mL respectively. All the subsequent fractions exhibited moderate to
high AChE inhibition i.e., Rh. Cr, Rh. Hex, Rh. Chf, Rh. EtAc and Rh. Aq showed IC50 218, 1420, 75, 115 and 1210 μg/mL
respectively. Similarly, against BChE various plant extracts i.e., Rh. Sp, Rh. Fl, Rh. Cr, Rh. Hex, Rh. Chf, Rh. EtAc and Rh. Aq
resulted IC50 165, 175, 265, 890, 92, 115 and 220 μg/mL respectively. In DPPH free radical scavenging assay, Rh. Sp and
Rh. Fl showed comparable results with the positive control i.e., 63.34 ± 0.98 and 76.93 ± 1.13% scavenging at 1 mg/mL
concentration (IC50 312 and 104 μg/mL) respectively. The percent ABTS radical scavenging potential exhibited by Rh.
Sp and Rh. Fl (1000 μg/mL) were 82.58 ± 0.52 and 88.25 ± 0.67 with IC50 18 and 9 μg/mL respectively. Similarly in H2O2
scavenging assay, the Rh. Sp and Rh. Fl exhibited IC50 175 and 275 μg/mL respectively.
Conclusion: The strong anticholinesterase and antioxidant activities of Rh. Sp, Rh. Fl and various fractions of R. hastatus
support the purported ethnomedicinal uses and recommend R. hastatus as a possible remedy for the treatment of AD
and neurodegenerative disorders.
Keywords: Ethnomedicinal, Acetylcholinesterase, Butyrycholinesterase, DPPH, ABTS, H2O2Background
According to WHO report 2001, round the world 25%
individuals suffer from mental/neurological disorders in
their life time [1]. The most common neurological disor-
ders are epilepsy, headache, migraine, susto (fright), mad-
ness, numbness, insomnia, stress, depression, alzeimer’s
disease, parkinson’s disease, anxiety etc [2,3]. In developed* Correspondence: ayazuop@gmail.com
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proper preventative measures, rehabilitation and im-
proved monitoring of patients. But in developing and
underdeveloped countries, the patients suffering from
different diseases primarily rely on traditional practi-
tioners and herbal medicine. The traditional use of
herbal medicine is as old as the history of man. Even
today the herbal medicine is utilized in sizable portion
of world’s population. As far as the use of traditional
medicine for the neurological diseases are concerned,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Ahmad et al. Biological Research  (2015) 48:20 Page 2 of 8the scientific validation of various medicinal plants sup-
ports their traditional uses and have led to development
of novel drugs [4,5]. Large numbers of natural bioactive
compounds have been derived from various plants spe-
cies based on their traditional knowledge. For example
the Ginkgo biloba was traditionally perceived as mem-
ory enhancer and was considered as anti-ageing which
was scientifically verified but later on it was also con-
firmed that it is effective in the treatment of mild to mod-
erate alzeimer’s disease [6-8]. Similarly galanthamine a
drug used against AD that is derived from Galanthus
nivalis is also the outcome of traditional knowledge. It has
been reported in detail that Galanthamine basically in-
creases acetylcholine level in synapsis by inhibiting the
acetylcholinesterase responsible for the breakdown of
acetylcholine. AD occurs as a result of decreased choliner-
gic transmission, increased oxidative stress, increased in-
flammatory condition, increased β-amyloid formation,
decreased nerve growth factors etc [9]. But for the treat-
ment of AD only cholinesterase inhibitors are considered
primarily. The other factors responsible for AD are not
emphasized as the cholinergic transmission, yet they are
having ample importance.
The ethnomedicinal uses of flora make it easy to know
the latent potentials of a specific plant specie. R. hasta-
tus, one of the members of polygonaceae has wide var-
iety of traditional uses, for examples, it is commonly
used as laxative, alterative, tonic, in rheumatism [10], in
skin diseases, piles, bilious complaints and lungs bleed-
ing [11]. The juice of R. hastatus is used to treat blood
pressure [12], in tonsillitis and sore throat [13], as flavor-
ing agent, carminative and diuretic [14]. Similarly it has
also been reported to be used traditionally against giddi-
ness and insanity [15]. As far as other species of Rumex
are concerned, majority of them are traditionally being
used for various neurological disorders i.e., R. acetosa is
traditionally used in paralysis [16], R. abyssinicus is used
for the treatment of migraine, headache, rabies [17], R.
tuberosus is used as tension regulator [18] and R. nepa-
lensis, R. maderensis are also used in headache [19,20].
Moreover the R. patientia has been scientifically con-
firmed to improve memory and passive avoidance learn-
ing [21]. Antioxidant activities of several species of
Rumex have been reported while the anticholinesterase
activities are still to be scientifically confirmed [22,23].
Almost all the species of a specific genus resembles con-
siderably due to genome similarity among the species of
the same genus [24]. As discussed earlier, the species of
Rumex are traditionally being used in paralysis, headache
and other CNS disorders so it provide an ethnomedicinal
evidence for the presence of cholinergic transmission
enhancing principles in this genus. Based on the previous
literature and ethnomedicinal uses, this investigational
study is designed to uncover the anticholinesterase andantioxidant potentials of various samples of R. hastatus
and to provide a bridge between the traditional and scien-
tific knowledge.
Results
Phytochemical screening and extraction yields
The preliminary phytochemical screening of R. hastatus
confirmed the presence of alkaloids, saponins, anthra-
quinone glycoside, tannins and flavonoids. The extrac-
tion yield of Rh. Sp and Rh. Fl of R. hastatus was 6.5
and 8% respectively.
Acetylcholinesterase inhibition assay
The most prominent AChE inhibition of various sam-
ples of R. hastatus was recorded for Rh. Sp and Rh. Fl.
The percent AChE inhibition observed for Rh. Sp were
81.67 ± 0.88, 72.87 ± 1.27, 60.95 ± 2.01 and 49.08 ± 1.04
at the concentration of 1000, 500, 250 and 125 μg/mL
respectively with IC50135 μg/mL, while the Rh. Fl
displayed 91.62 ± 1.67, 84.76 ± 0.61, 81.03 ± 0.86 and
67.70 ± 0.92% AChE inhibition at afore mentioned con-
centrations with IC50 20 μg/mL. Among the resultant
fractions the Rh. Chf revealed good results as shown in
Table 1. All the fractions showed concentration dependent
activity. The IC50 calculated for Rh. Cr, Rh. Hex, Rh. Chf, Rh.
EtAc and Rh. Aq were 218, 1420, 75, 115 and 1210 μg/mL
respectively, in which Rh. Chf was observed as most potent.
Butyrylcholinesterase inhibition assay
In BChE inhibition assay, Rh. Fl and Rh. Sp excelled
among all the test samples. The percent BChE inhib-
ition calculated for Rh. Sp were 77.52 ± 3.28, 63.93 ±
0.67, 61.83 ± 1.21 and 42.22 ± 1.28 at 1000, 500, 250
and 125 μg/mL respectively with IC50 165 μg/mL. Rh.
Fl displayed 79.16 ± 0.86, 77.98 ± 0.72, 59.65 ± 0.98 and
41.93 ± 1.01% BChE inhibition at afore mentioned con-
centrations with IC50 175 μg/mL. Similarly all the frac-
tions showed moderate to high activity and the IC50
calculated for Rh. Cr, Rh. Hex, Rh. Chf, Rh. EtAc and
Rh. Aq were 265, 890, 92, 115 and 220 μg/mL respect-
ively against BChE as shown in the Table 1. Briefly the
BChE inhibition observed for each plant samples were
dose dependent and the results of Rh. Fl and Rh. Sp
were almost comparable with the positive control.
DPPH radical scavenging effect
The antioxidant activity of Rh. Sp and Rh. Fl against
DPPH free radicals displayed a dose dependent response.
The DPPH scavenging potential of Rh. Fl was comparable
with ascorbic acid while the Rh. Sp displayed a moderate
antioxidant activity in comparison with the positive con-
trol. The percent radical scavenging potentials of Rh. Sp
were 63.34 ± 0.98, 56.32 ± 1.06, 48.05 ± 0.75, 44.70 ± 1.25
and 38.74 ± 0.68 at the concentrations of 1000, 500,
Table 1 Percent AChE and BChE inhibition potential of various samples of Rumex hastatus
Samples Concentrations (μg/mL) Percent AChEI Percent BChEI
AChEI IC50 BChEI IC50
(mean ± S.E.M) (μg/mL) (mean ± S.E.M) (μg/mL)
Rh.Cr 1000 65.33 ± 0.49*** 69.58 ± 1.12***
500 59.03 ± 0.23*** 218 63.65 ± 1.34*** 265
250 52.03 ± 0.48*** 49.31 ± 2.15***
125 39.00 ± 0.58*** 41.03 ± 0.48***
Rh. Hex 1000 42.67 ± 0.89*** 51.44 ± 0.58***
500 39.00 ± 1.15*** 1420 46.90 ± 0.96*** 890
250 38.00 ± 0.00*** 39.28 ± 2.19***
125 29.03 ± 0.23*** 32.70 ± 1.60***
Rh. Chf 1000 76.70 ± 1.60*** 75.76 ± 0.71***
500 71.73 ± 0.78*** 75 65.65 ± 1.32*** 92
250 68.70 ± 1.60*** 61.23 ± 1.83***
125 52.90 ± 0.52*** 53.13 ± 0.20***
Rh. EtAc 1000 77.23 ± 0.40*** 74.56 ± 1.06***
500 69.90 ± 0.43*** 115 66.42 ± 0.43*** 115
250 55.90 ± 0.20*** 59.42 ± 0.46***
125 51.13 ± 0.20*** 51.87 ± 1.27***
Rh.Aq 1000 46.20 ± 0.23*** 61.03 ± 0.35***
500 38.80 ± 0.37*** 1210 52.08 ± 0.47*** 220
250 37.90 ± 0.48*** 51.91 ± 0.88***
125 31.74 ± 0.68*** 44.90 ± 0.96***
Rh.Sp 1000 81.67 ± 0.88*** 77.52 ± 3.28***
500 72.87 ± 1.27*** 135 63.93 ± 0.67*** 165
250 60.95 ± 2.01*** 61.83 ± 1.21***
125 49.08 ± 1.04*** 42.22 ± 1.28***
Rh.Fl 1000 91.62 ± 1.67** 79.16 ± 0.86***
500 84.76 ± 0.61*** 20 77.98 ± 0.72*** 175
250 81.03 ± 0.86 ns 59.65 ± 0.98***
125 67.70 ± 0.92 ns 41.93 ± 1.01***
Gal 1000 96.00 ± 0.30 88.61 ± 0.43
500 91.26 ± 1.27 20 83.25 ± 1.40 47
250 82.91 ± 1.30 74.03 ± 0.86
125 69.91 ± 0.89 61.22 ± 1.28
Data is represented as mean ± S.E.M; n = 3, * represent level of significance like; * = P < 0.05, ** = P < 0.01, *** = P < 0.001.
Gal : Galanthamine.
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mL. The Rh. Fl demonstrated 76.93 ± 1.13, 64.74 ± 1.29,
61.42 ± 0.57, 52.34 ± 1.01 and 46.73 ± 0.78% radicals
scavenging potentials at 1000, 500, 250, 125 and 62.5 μg/mL
respectively with IC50 104 μg/mL as shown in the Table 2.
H2O2 scavenging effect
The antioxidant activity of R. hastatus against hydrogen
peroxide revealed good results for Rh. Sp. The Rh. Fl
demonstrated good antioxidant activity with IC50 275μg/mL, which was comparable with the positive con-
trol. The percent hydrogen peroxide scavenging poten-
tials exhibited by Rh. Sp were 29.13 ± 0.20, 37.85 ± 0.97,
44.82 ± 0.82, 56.90 ± 0.78 and 65.70 ± 1.25 at the con-
centrations of 62.5, 125, 250, 500 and 1000 μg/mL re-
spectively with the IC50 of 175 μg/mL. At the highest
concentration, i.e., 1000 μg/mL the Rh. Fl and positive
control exhibited 54.34 ± 1.01 and 54.17 ± 1.69% inhibi-
tions respectively while the Rh. Sp demonstrated 65.70
± 1.25% antioxidant potentials as shown in Figure 1.
Table 2 Percent DPPH radical scavenging potential of







Rh. Sp 1000 63.34 ± 0.98***
500 56.32 ± 1.06*** 312
250 48.05 ± 0.75***
125 44.70 ± 1.25***
62.5 38.74 ± 0.68***
Rh.Fl 1000 76.93 ± 1.13ns
500 64.74 ± 1.29ns 104
250 61.42 ± 0.57ns
125 52.34 ± 1.01ns
62.5 46.73 ± 0.78ns
A.A 1000 77.17 ± 0.72
500 67.65 ± 1.47 95
250 62.85 ± 0.97
125 53.37 ± 1.65
62.5 47.87 ± 0.26
Data is represented as mean ± S.E.M; n = 3. * represent level of significance
































Figure 1 Percent H2O2 scavenging effect of flavonoids and saponins of
Data is represented as mean ± S.E.M.
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The ABTS radical scavenging activity of Rh. Sp and Rh.
Fl of R. hastatus was more prominent in comparison to
other antioxidant assays. Both the plant samples exhib-
ited very low IC50 values in this activity. The Rh. Fl dis-
played 88.25 ± 0.67, 82.23 ± 0.39, 74.92 ± 1.08, 70.53 ±
0.90 and 61.70 ± 1.60% ABTS radical scavenging po-
tential at the concentrations of 1000, 500, 250, 125 and
62.5 μg/mL respectively with the IC50 of 9 μg/mL. The
Rh. Sp showed the IC50 value of 18 μg/mL, which was
larger (less potent) than those of Rh. Fl (IC50 = 9 μg/mL)
and positive control (IC50 = 5 μg/mL). Briefly the ABTS
radical scavenging activity of samples of R. hastatus re-
vealed remarkable results with dose dependent response
as shown in the Figure 2.
Discussions
Acetylcholine, an extensively distributed neurotransmit-
ter especially in the central nervous system has a key
role in transmission of signal across the synapses, cere-
bral blood flow, cognitive performance and coordination.
The decreased level of acetylcholine within the nervous
system of the body may be due to reduced acetyltrans-
ferase or increased level of AChE. These two factors are
correlated with dementia and AD. The hydrolysis of
acetylcholine is decreased by inhibiting AChE in the brain
[25,26]. There are numerous evidences which support the
deteriorating action of free radicals, which can lead to cog-











Rumex hastatus along with ascorbic acid at various concentrations.
Figure 2 Percent ABTS radical scavenging effect of flavonoids and saponins of Rumex hastatus along with ascorbic acid at various
concentrations. Data is represented as mean ± S.E.M.
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sumption of fruits and vegetables rich in flavonoids, which
possess the ability to neutralize the free radicals [28]. It
has already been reported that the cognitive performance
can be significantly improved by taking diet rich in anti-
oxidant species especially the flavonoids [29,30]. It is be-
lieved that the natural products are safe as compared to
synthetic compounds [31]. Due to great interest towards
the natural products, the scientists are trying to investigate
more and more plants for the presence of effective com-
pounds, which may cure a specific disease. The presence
of thousands of flavonoids has been confirmed in more
than 3000 plant species. Flavonoids have been reported to
be significantly effective in cholinesterase inhibition, i.e.,
Leufolins A and B (flavonoids) isolated from Leucas urtici-
folia have been scientifically verified to possess strong
BChE inhibitory potential [32]. It is also obvious of our
current investigations that Rh.Fl possess comparable anti-
cholinesterase potential with the positive control (galanta-
mine). Similarly the saponins are also prominent secondary
metabolites, which have been verified to possess various
beneficial pharmacological potentials. For instant, the sapo-
nins isolated from traditional Chinese medicines have
demonstrated excellent antioxidant activity [33]. As obvi-
ous of the current investigational data, the Rh.Sp demon-
strated good antioxidant and significant anticholinesterase
potential. Similarly the antioxidant potential of Rh.Sp
against ABTS was comparable to the positive control
and Rh.Fl as shown in the Figure 2. The current investi-
gation and the literature review intimates the presenceof anticholinesterase compounds in Rh.Sp and Rh.Fl of
R. hastatus just like the saponins (Bacosides) of Bacopa
monnieri and the flavonoids (ginkgoflavonglycosides) of
Ginkgo biloba [34]. Among the subsequent fractions
the excellent activity of Rh.Chf and Rh.EtAc represents
that the saponins and flavonoids may be concentrated
in the said fractions. The previously reported data also
goes parallel with our current investigation i.e., in the
current study the Rh.Fl has shown significant antioxi-
dant potential and in the previous reports, the fractions
(chloroform, ethyl acetate and butonal) having high
quantity of total phenolics and total flavonoids content
had shown significant antioxidant activity as reported
by Sehreen et al and Afzal et al [35,36]. Likewise several
other plant species have been reported to possess mul-
tiple pharmacological activities [37-39].Conclusions
The thorough literature survey and the results of our
current investigation support the potential role of R. has-
tatus in the treatment of nervous disorders. Similarly,
based on the significant enzymes (AChE, BChE) inhibition
and radicals scavenging demonstrations of various sam-
ples of R. hastatus, it may be inferred that the Rh. Fl and
Rh. Sp of R. hastatus may be the best sources of antioxi-
dant and anticholinesterase compounds. The bioguided
isolation of R. hastatus is in progress in our laboratory,
which may lead to new anti-Alzheimer’s disease and anti-
ageing candidates.
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Plant collection, extraction and fractionation
The whole plant of R. hastatus was collected from the
hilly area of Gorha Gat nearby University of Malakand,
Chakdara (Lower dir) KPK, Pakistan. The plant was iden-
tified by plant taxonomist Ali Hazrat and deposited with
voucher number (1015SJ) in the herbarium, Department
of Botany, Shaheed Benazir Bhutto University, Sheringal
(Dir Upper) KPK, Pakistan. All the extra particles (sand
and dust) were thoroughly removed from the plant and
was scattered on neat paper in a room protected from
sunlight and properly shade dried for 20 days. The paper
was changed every day to avoid fungal growth. After shade
drying the plant material was converted into coarse parti-
cles using cutter mill. The powdered plant sample (4 kg
approximately) was subjected to maceration in 80%
methanol and filtered after 15 days using muslin cloth.
The filtrate was concentrated using rotary evaporator and
then solidified using water bath at 40°C yielding 300 g of
crude methanolic extract. The crude methanolic extract
obtained (260 g) was subject to fractionation using suc-
cessive solvent-solvent extraction process starting from
n-hexane, chloroform, ethyl acetate and water yielding 30,
22, 53 and 140 g of Rh. Hex, Rh. Chf, Rh. EtAc and Rh.
Aq respectively [40].
Extraction of crude saponins
For the extraction of Rh. Sp from R. hastatus, 20 g pow-
dered plant was added to 100mL ethanol (20%). The
sample was heated at 55°C in water bath for four hours
with continuous stirring. After four hours the sample
obtained was filtered and the residue having greenish
color was re-extracted with 200 mL of 20% ethanol. The
sample after extraction was heated until a concentrated
volume of 40 mL was obtained. Then it was transferred
into a separating funnel and 20 mL of diethyl ether was
added to it. After vigorous shaking, the separating funnel
was put in a stand to get two layered sample. The lower
layer was collected, which was aqueous layer while the
upper diethyl ether layer was discarded. The aqueous
layer obtained was diluted with 60 mL of n-butanol and
the combined n-butanol extract was washed with 10 mL
of 5% sodium chloride solution. The final solution ob-
tained was kept in a hot water bath until complete evap-
oration and the Rh. Sp obtained were dried in an oven
yielding 1.3 g of Rh. Sp [41].
Extraction of flavonoids
For the extraction of flavonoids from R. hastatus, the pro-
cedure of Harborne was followed [42]. Powdered plant
sample weighing 20 g was heated at 50°C in 200 mL of
2M HCl under reflux for half an hour. It was cooled and
filtered using whatman No.42 filter paper. The filtrate was
treated with equal volume of ethyl acetate. The Rh.Flpresent in the extract were precipitated, which were re-
covered with the help of weighed filter paper. The weight
of Rh.Fl obtained was 1.6 g (8%) [43].
Preliminary phytochemical screening
The preliminary phytochemical screening of the R. has-
tatus was carried out to determine the existence of alka-




Electric eel acetylcholinesterase (type-VI-S, Sigma-Aldrich
USA), Aquine butyrylcholinesterase (Sigma-Aldrich USA),
Acetylthiocholine Iodide (Sigma-Aldrich UK), Butyrylthio-
cholin iodide (Sigma-Aldrich Switzerland), 5,5-dithio-bis-
nitrobenzoic acid (DTNB) (Sigma-Aldrich Germany),
Potassium phosphate buffer (pH 8.0), Galantamine from
Lycoris Sp. (Sigma-Aldrich France).
Spectroscopic analysis
AChE and BChE inhibition was assessed spectrophoto-
metrically for Rh. Fl and Rh. Sp using Acetylthiocholine
iodide and Butyrylthiocholine iodide as substrate follow-
ing the method of Ellman [45]. In this method, 5 μL of
AChE (0.03 U/mL) and BChE (0.01 U/mL) were taken in
a cuvette and 205 μL of plant samples (125–1000 μg/mL)
were added to them. DTNB (5 μL) was added to the mix-
ture, transferred to a water bath having temperature of
30°C and incubated for 15 minutes. Substrates having vol-
ume of 5 μL were added to the mixture to start the reac-
tion. The reaction mixture was analyzed at 412 nm using
a double beam spectrophotometer. Absorption was re-
corded for 4 minutes. The formation of yellow color indi-
cated the formation of 5-thio-2-nitrobenzoate anion as a
result of the reaction between thiocholines and DTNB. To
check the non-enzymatic hydrolysis of substrate, white
assay was carried out without enzymes and plant samples.
The reaction mixture containing all the components ex-
cluding plant sample was taken as control. Percent en-
zyme activity and percent inhibition were figured out as
follows.
V ¼ ΔAbs=Δt
% enzyme activity ¼ V=Vmax 100
% enzyme inhibition ¼ 100‐% enzyme activity
(Where V denotes rate of reaction in the present of
inhibitor and Vmax denotes rate of reaction without
inhibitor).
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The method of Brand-Williams et al. [46] with some
modifications was followed for the DPPH assay. DPPH
(24 mg) was dissolved in 100 mL of methanol to get
DPPH solution. The stock solutions of plant samples
having concentrations of 1 mg/mL were prepared in
methanol and then diluted to the concentrations of 500,
250, 125, 62.5 μg/mL. 0.1 mL diluted solution of each
sample was mixed with 3 mL of DPPH solution in
methanol. The solution was incubated at 23°C for 30 mi-
nutes and then the absorbance was measured at 517 nm.
For positive control ascorbic acid was used. Each con-
centration was taken in triplicate and the data obtained
was presented as mean ± S.E.M. The percent radical
scavenging activity was calculated using the following
equation:
Percent scavenging effect
¼ control absorbance−sample absorbance
control absorbance
 100:
Hydrogen peroxide scavenging assay
The hydrogen peroxide scavenging activity of samples
was conducted following the procedure of Ruch et al
[47]. Hydrogen peroxide solution (2 mM) was prepared
in 50 mM phosphate buffer having the pH of 7.4. Vari-
ous plant samples having volume of 0.1 mL were taken
in test tubes and their volumes were made 0.4 mL by
addition of 50mM phosphate buffer. Hydrogen peroxide
solution (0.6 mL) was added to it and vertexed. After 10
minutes the absorbance of each sample was measured at
230nm against the blank. The hydrogen peroxide scav-
enging activity was measured using the following
equation:
Hydrogen peroxide scavenging activity




ABTS free radical scavenging assay
Antioxidant potentials of Rh. Sp and Rh. Fl were
assessed using the free radicals of 2, 2-azinobis [3-ethyl-
benzthiazoline]-6-sulfonic acid (ABTS) [48]. Solutions of
ABTS 7 mM and potassium persulfate 2.45 mM were
prepared and thoroughly mixed. The solution was kept
overnight in dark to produce free radicals. After incuba-
tion the absorbance of ABTS solution was adjusted to
0.7 at 745 nm by the addition of 50% methanol. Then
300 μl of test samples were taken and 3 mL of ABTS so-
lution was added to it. The solution obtained was trans-
ferred to cuvette and absorbance of was measured using
a double beam spectrophotometer for six minutes. Forpositive control Ascorbic acid was used. The data was
recorded in triplicate and percent ABTS free radicals
scavenging activity was calculated as follows:
Percent scavenging activity
¼ control absorbance−sample absorbance
control absorbance
 100:
Estimation of IC50 values
Concentrations of test samples, which inhibited sub-
strate hydrolysis (AChE and BChE) by 50% (IC50). Rad-
ical scavenging activity was determined by a linear
regression analysis among the percent inhibition against
the test samples concentrations via MS Excel program.
Statistical data analysis
All the tests were performed in triplicate and values
were expressed as means ± S.E.M. Significance between
radical scavenging activity and test samples were ana-
lyzed using Mann-Whitney U test. Group comparison
was performed by Student’s t-test in which the P < 0.05
were considered significant.
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